• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    iRhythm Holdings, Inc. - Common Stock (NQ:IRTC)

    111.43 -2.23 (-1.96%)
    Delayed Quote Updated: 1:18 PM EDT, Oct 1, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about iRhythm Holdings, Inc. - Common Stock

    < Previous 1 2
    ...
    11 12 13 14 15 16 17 18 Next >
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Gainers Glaukos (NYSE:GKOS) stock increased by 25.55% to $56.58 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.6 billion... 
    Via Benzinga
    News headline image
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
    Good morning, trader! We're starting the day off right with a dive into the biggest pre-market stock movers for Wednesday! 
    Via InvestorPlace
    News headline image
    25 Stocks Moving in Wednesday's Pre-Market Session ↗
    Gainers Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 56.4% to $26.20 in pre-market trading on the heels of three new announcements from the company outlining strategic plans to... 
    Via Benzinga
    News headline image
    The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline ↗
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)... 
    Via Benzinga
    News headline image
    The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (... 
    Via Benzinga
    News headline image
    7 Robotics Stocks to Buy to Ride the Automation Wave ↗
    The world is going through a massive logistics meltdown. Automation will be a key part of the solution, making these robotics stocks buys. 
    Via InvestorPlace
    Why A.I. Is About To Trigger The Next Great Medical Breakthrough
    FN Media Group Presents Oilprice.com Market Commentary London – October 21, 2021 – The healthcare industry is one of the fastest growing in the world, but today, it’s seeing a major disruption. With... 
    Via FinancialNewsMedia
    Topics Artificial Intelligence
    News headline image
    Here's Why iRhythm Technologies Stock Is Making Big Gains Today ↗
    A new CEO with an impressive record is giving investors hope for a rapid turnaround for the heart monitor maker. 
    Via The Motley Fool
    News headline image
    12 Health Care Stocks Moving In Monday's Intraday Session ↗
    Gainers Itamar Medical (NASDAQ:ITMR) shares increased by 46.58% to $30.25 during Monday's regular session. Trading volume for Itamar Medical's stock is 2.6 million... 
    Via Benzinga
    News headline image
    72 Biggest Movers From Yesterday ↗
    Gainers aTyr Pharma, Inc. (NASDAQ: LIFE) jumped 67% to settle at $9.15 on Monday as the company announced positive results from its Phase 1b/2a trial evaluating its lead... 
    Via Benzinga
    News headline image
    45 Stocks Moving In Monday's Mid-Day Session ↗
    Gainers Aterian, Inc. (NASDAQ: ATER) jumped 54.1% to $18.18. Investor presentation released on Friday is now circulating on news outlets. Itamar Medical Ltd. (NASDAQ: ITMR)... 
    Via Benzinga
    News headline image
    IRTC Stock: 7 Things to Know About Digital Healthcare Play iRhythm Technologies as Shares Soar ↗
    Irhythm Technologies (IRTC) stock is taking off on Monday after announcing Quentin Blackford as its next CEO and we have more to know. 
    Via InvestorPlace
    News headline image
    Mid-Morning Market Update: Markets Mixed; UK Terminates Valneva's COVID-19 Vaccine Contract ↗
    Following the market opening Monday, the Dow traded up 0.61% to 34,817.26 while the NASDAQ fell 0.40% to 15,055.69. The S&P also rose, gaining 0.05% to 4,460.84. The U.S. has... 
    Via Benzinga
    Topics Stocks
    News headline image
    Looking into iRhythm Technologies's Return on Capital Employed ↗
    After pulling data from Benzinga Pro it seems like during Q2, iRhythm Technologies's (NASDAQ:IRTC) reported sales totaled $81.28 million. Despite a 38.14% in earnings, the company... 
    Via Benzinga
    News headline image
    iRhythm Technologies Inc (IRTC) Q2 2021 Earnings Call Transcript ↗
    IRTC earnings call for the period ending June 30, 2021. 
    Via The Motley Fool
    Topics Earnings
    News headline image
    Stocks That Hit 52-Week Lows On Tuesday ↗
    Before 10 a.m. ET on Tuesday, 48 companies set new 52-week lows. Interesting Highlights: Marqeta (NASDAQ:MQ) was the largest company by market cap to set a new 52-... 
    Via Benzinga
    News headline image
    The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data ↗
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS... 
    Via Benzinga
    News headline image
    The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck ↗
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)... 
    Via Benzinga
    News headline image
    The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO ↗
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (... 
    Via Benzinga
    News headline image
    The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma ↗
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... 
    Via Benzinga
    News headline image
    The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO ↗
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)... 
    Via Benzinga
    News headline image
    Stocks That Hit 52-Week Lows On Thursday ↗
    During Thursday's morning session, 77 companies made new 52-week lows. Areas of Interest: The largest company in terms of market cap to set a new 52-week low... 
    Via Benzinga
    News headline image
    Stocks That Hit 52-Week Lows On Monday ↗
    On Monday morning, 16 companies achieved new lows for the year. Points of Interest: The largest company in terms of market cap to set a new 52-week low was Tencent... 
    Via Benzinga
    News headline image
    The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗
    Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
    Via Benzinga
    News headline image
    The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts ↗
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI... 
    Via Benzinga
    News headline image
    The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street ↗
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated... 
    Via Benzinga
    News headline image
    The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study ↗
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) IVERIC bio, Inc. (NASDAQ:... 
    Via Benzinga
    Topics Stocks
    News headline image
    The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs ↗
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 14) Alexion Pharmaceuticals,... 
    Via Benzinga
    Topics Product Recall
    News headline image
    The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues ↗
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Biohaven Pharmaceutical... 
    Via Benzinga
    News headline image
    The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data ↗
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 12) AbbVie Inc. (NYSE: ABBV)... 
    Via Benzinga
    < Previous 1 2
    ...
    11 12 13 14 15 16 17 18 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.